Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Merck & Co., Inc. logo
MRK
Merck & Co., Inc.
20:02:34
113.87 $
0.0000 (%0.00)
Previous Close: 115.44
Day Low111.57
Day High114.94
Bid
Ask

MRK: Merck & Co., Inc. Financials

Merck & Co., Inc. Income Statement

Total revenue
Net income
Gross margin TTM
71.98%
Operating margin TTM
36.17%
Net profit margin TTM
28.12%
Return on investment TTM
34.7%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue64,926,000,00064,168,000,00060,115,000,00059,283,000,000
Operating income23,486,000,00020,221,000,0002,954,000,00018,282,000,000
Net income18,254,000,00017,117,000,000365,000,00014,519,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue64,926,000,00064,168,000,00060,115,000,00059,283,000,000
Cost of revenue18,195,000,00015,193,000,00016,126,000,00017,411,000,000
Gross profit46,731,000,00048,975,000,00043,989,000,00041,872,000,000
Research and development expenses12,514,000,00017,938,000,00030,531,000,00013,548,000,000
General and administrative expenses07,700,000,0007,584,000,0007,469,000,000
Selling and marketing expenses02,400,000,0002,300,000,0002,200,000,000
Selling, general and administrative expenses10,731,000,00010,100,000,0009,884,000,0009,669,000,000
Other expenses0716,000,000620,000,000373,000,000
Operating expenses23,245,000,00028,754,000,00041,035,000,00023,590,000,000
Cost and expenses41,440,000,00043,947,000,00057,161,000,00041,001,000,000
Net interest income-1,014,000,000-856,000,000-781,000,000-805,000,000
Interest income343,000,000415,000,000365,000,000157,000,000
Interest expense1,357,000,0001,271,000,0001,146,000,000962,000,000
Depreciation and amortization5,838,000,0004,499,000,0003,872,000,0003,909,000,000
EBITDA28,262,000,00025,706,000,0006,907,000,00021,315,000,000
EBIT22,424,000,00021,207,000,0003,035,000,00017,406,000,000
Non-operating income (excl. interest)1,062,000,000-986,000,000-81,000,000876,000,000
Operating income23,486,000,00020,221,000,0002,954,000,00018,282,000,000
Total other income/expenses (net)-2,419,000,000-285,000,000-1,065,000,000-1,838,000,000
Income before tax21,067,000,00019,936,000,0001,889,000,00016,444,000,000
Income tax expense2,804,000,0002,803,000,0001,512,000,0001,918,000,000
Net income from continuing operations18,263,000,00017,133,000,000377,000,00014,526,000,000
Net income from discontinued operations0000
Other adjustments to net income0000
Net income18,254,000,00017,117,000,000365,000,00014,519,000,000
Net income deductions0000
Bottom line net income18,254,000,00017,117,000,000365,000,00014,519,000,000
EPS770.146
Diluted EPS770.146
Weighted average shares outstanding2,502,000,0002,532,000,0002,607,143,0002,532,000,000
Weighted average diluted shares outstanding2,507,000,0002,541,000,0002,547,000,0002,542,000,000

Merck & Co., Inc. Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
Current ratio MRQ
Long-term debt / assets MRQ
46,750,000,000%
Total debt / assets MRQ
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets136,866,000,000117,106,000,000106,675,000,000109,160,000,000
Total liabilities84,204,000,00070,734,000,00069,040,000,00063,102,000,000
Total equity52,606,000,00046,313,000,00037,581,000,00045,991,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents14,565,000,00013,242,000,0006,841,000,00012,694,000,000
Short-term investments0447,000,000252,000,000498,000,000
Cash and short-term investments14,565,000,00013,689,000,0007,093,000,00013,192,000,000
Net receivables12,679,000,00010,278,000,00010,349,000,0009,450,000,000
Accounts receivable11,775,000,00010,278,000,00010,349,000,0009,450,000,000
Other receivables904,000,000000
Inventory6,658,000,0006,109,000,0006,358,000,0005,911,000,000
Prepaid expenses0000
Other current assets9,489,000,0008,706,000,0008,368,000,0007,169,000,000
Total current assets43,516,000,00038,782,000,00032,168,000,00035,722,000,000
Property, plant and equipment (net)26,823,000,00023,779,000,00023,051,000,00021,422,000,000
Goodwill21,579,000,00021,668,000,00021,197,000,00021,204,000,000
Intangible assets26,681,000,00016,370,000,00018,011,000,00020,269,000,000
Goodwill and intangible assets48,260,000,00038,038,000,00039,208,000,00041,473,000,000
Long-term investments2,239,000,000463,000,000252,000,0001,015,000,000
Tax assets0000
Other non-current assets16,028,000,00016,044,000,00011,996,000,0009,528,000,000
Total non-current assets93,350,000,00078,324,000,00074,507,000,00073,438,000,000
Other assets0000
Total assets136,866,000,000117,106,000,000106,675,000,000109,160,000,000
Total payables11,270,000,00010,077,000,0008,556,000,0008,134,000,000
Accounts payable4,404,000,0004,079,000,0003,922,000,0004,264,000,000
Other payables6,866,000,0005,998,000,0004,634,000,0003,870,000,000
Accrued expenses85,000,00015,694,000,00015,766,000,00014,159,000,000
Short-term debt2,883,000,0002,649,000,0001,372,000,0001,946,000,000
Capital lease obligations (current)0282,000,000285,000,000281,000,000
Tax payables03,914,000,0002,649,000,0001,986,000,000
Deferred revenue0000
Other current liabilities14,089,000,000-282,000,000-285,000,000-281,000,000
Total current liabilities28,327,000,00028,420,000,00025,694,000,00024,239,000,000
Long-term debt46,750,000,00034,462,000,00033,683,000,00028,745,000,000
Capital lease obligations (non-current)901,000,000877,000,000928,000,0001,013,000,000
Deferred revenue (non-current)0000
Deferred tax liabilities (non-current)1,439,000,0001,387,000,000871,000,0001,795,000,000
Other non-current liabilities6,787,000,0005,588,000,0007,864,000,0007,310,000,000
Total non-current liabilities55,877,000,00042,314,000,00043,346,000,00038,863,000,000
Other liabilities0000
Capital lease obligations901,000,0001,159,000,0001,213,000,0001,294,000,000
Total liabilities84,204,000,00070,734,000,00069,040,000,00063,102,000,000
Treasury stock-62,999,000,000-58,303,000,000-57,450,000,000-56,489,000,000
Preferred stock0000
Common stock1,788,000,0001,788,000,0001,788,000,0001,788,000,000
Retained earnings73,075,000,00063,069,000,00053,895,000,00061,081,000,000
Additional paid-in capital45,029,000,00044,704,000,00044,509,000,00044,379,000,000
Accumulated other comprehensive income/loss-4,287,000,000-4,945,000,000-5,161,000,000-4,768,000,000
Other stockholders' equity0000
Total stockholders' equity52,606,000,00046,313,000,00037,581,000,00045,991,000,000
Total equity52,662,000,00046,372,000,00037,635,000,00046,058,000,000
Minority interest56,000,00059,000,00054,000,00067,000,000
Total liabilities and total equity136,866,000,000117,106,000,000106,675,000,000109,160,000,000
Total investments2,239,000,000910,000,000504,000,0001,513,000,000
Total debt50,534,000,00038,270,000,00036,268,000,00031,985,000,000
Net debt35,969,000,00025,028,000,00029,427,000,00019,291,000,000

Merck & Co., Inc. Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
Revenue / share TTM
Operating cash flow TTM
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations16,472,000,00021,468,000,00013,006,000,00019,095,000,000
Cash from investing-13,741,000,000-7,734,000,000-14,083,000,000-4,960,000,000
Cash from financing-1,922,000,000-7,032,000,000-4,810,000,000-9,119,000,000
Net change in cash1,372,000,0006,409,000,000-5,864,000,0004,606,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income18,254,000,00017,133,000,000365,000,00014,526,000,000
Depreciation and amortization5,838,000,0004,499,000,0003,872,000,0003,909,000,000
Deferred income tax-1,671,000,000-1,249,000,000-1,899,000,000-1,568,000,000
Stock-based compensation0761,000,000645,000,000541,000,000
Change in working capital-6,976,000,000-3,667,000,000-2,205,000,000-2,782,000,000
Accounts receivable-1,090,000,000-244,000,000-1,148,000,000-644,000,000
Inventory-1,180,000,000-835,000,000-816,000,000-161,000,000
Accounts payable110,000,000182,000,000-380,000,000-289,000,000
Other working capital-4,816,000,000-2,770,000,000139,000,000-1,688,000,000
Other non-cash items1,027,000,0003,991,000,00012,228,000,0004,469,000,000
Net cash from operating activities16,472,000,00021,468,000,00013,006,000,00019,095,000,000
Investments in property, plant and equipment-4,112,000,000-3,372,000,000-3,863,000,000-4,388,000,000
Acquisitions (net)-10,042,000,000-4,093,000,000-12,032,000,000-121,000,000
Purchases of investments-1,207,000,000-519,000,000-955,000,000-1,204,000,000
Sales/maturities of investments1,678,000,000377,000,0001,658,000,000721,000,000
Other investing activities-58,000,000-127,000,0001,109,000,00032,000,000
Net cash from investing activities-13,741,000,000-7,734,000,000-14,083,000,000-4,960,000,000
Net debt issuance11,377,000,0002,309,000,0004,184,000,000-2,251,000,000
Long-term net debt issuance11,377,000,0002,309,000,0004,184,000,000-2,251,000,000
Short-term net debt issuance0000
Net stock issuance-4,992,000,000-1,306,000,000-1,346,000,000384,000,000
Net common stock issuance-4,992,000,000-1,306,000,000-1,346,000,000384,000,000
Common stock issuance92,000,00000384,000,000
Common stock repurchased-5,084,000,000-1,306,000,000-1,346,000,0000
Net preferred stock issuance0000
Net dividends paid-8,176,000,000-7,840,000,000-7,445,000,000-7,012,000,000
Common dividends paid-8,176,000,000-7,840,000,000-7,445,000,000-7,012,000,000
Preferred dividends paid0000
Other financing activities-131,000,000-195,000,000-203,000,000-240,000,000
Net cash from financing activities-1,922,000,000-7,032,000,000-4,810,000,000-9,119,000,000
Effect of FX changes on cash563,000,000-293,000,00023,000,000-410,000,000
Net change in cash1,372,000,0006,409,000,000-5,864,000,0004,606,000,000
Cash at end of period14,690,000,00013,318,000,0006,909,000,00012,773,000,000
Cash at beginning of period13,318,000,0006,909,000,00012,773,000,0008,167,000,000
Operating cash flow16,472,000,00021,468,000,00013,006,000,00019,095,000,000
Capital expenditure-4,112,000,000-3,372,000,000-3,863,000,000-4,388,000,000
Free cash flow12,360,000,00018,096,000,0009,143,000,00014,707,000,000
Income taxes paid0000
Interest paid0000